Gene: CD300LD
Official Full Name: CD300 molecule like family member dprovided by HGNC
Gene Summary: Predicted to enable transmembrane signaling receptor activity and virus receptor activity. Predicted to be involved in immune response-activating signaling pathway. Predicted to act upstream of or within regulation of interleukin-6 production and regulation of tumor necrosis factor production. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA01953 | CD300LD Knockout cell line (AC16) | Human | CD300LD | 1:3-1:4 | negative | Online Inquiry |
| KOA17396 | CD300LD Knockout cell line (BEAS-2B) | Human | CD300LD | 1:3~1:4 | negative | Online Inquiry |
| KOA32845 | CD300LD Knockout cell line (U-2932) | Human | CD300LD | 1:2-1:4 | negative | Online Inquiry |
| KOA48255 | CD300LD Knockout cell line (TPC-1) | Human | CD300LD | 1:5-1:8 | negative | Online Inquiry |
| KOA63655 | CD300LD Knockout cell line (NCM460) | Human | CD300LD | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.